- Home
- ENTX
ENTX
Entera Bio Ltd.
as 12-18-2024 9:49am EST
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
| Founded: | 2010 | Country: | Israel |
| Employees: | N/A | City: | JERUSALEM |
| Market Cap: | 67.2M | IPO Year: | 2018 |
| Target Price: | $10.00 | AVG Volume (30 days): | 54.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.52 - $3.35 | Next Earning Date: | 11-08-2024 |
| Revenue: | $99,000 | Revenue Growth: | 607.14% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Entera Bio Ltd. News
ENTX Breaking Stock News: Dive into ENTX Ticker-Specific Updates for Smart Investing
Zacks
a month ago
Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
a month ago
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
Zacks
2 months ago
Are Medical Stocks Lagging Argenx (ARGX) This Year?
Zacks
3 months ago
ENTX & OPK Stock May Gain Following Positive PK/PD Research Data
GlobeNewswire
3 months ago
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
Zacks
3 months ago
Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year?
Zacks
4 months ago
Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?
Simply Wall St.
4 months ago
We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
Compare ENTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ENTX Entera Bio Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.